These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27179966)

  • 41. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
    Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients.
    Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.
    Buchsbaum MS; Hazlett EA
    Schizophr Bull; 1998; 24(3):343-64. PubMed ID: 9718628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
    Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
    Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of SPECT measurements of D2 and 5-HT2A occupancy to the clinical development of the antipsychotic SB-773812.
    Catafau AM; Bullich S; Nucci G; Burgess C; Gray F; Merlo-Pich E;
    J Nucl Med; 2011 Apr; 52(4):526-34. PubMed ID: 21421726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opposite alterations of 5-HT
    Diez-Alarcia R; Muguruza C; Rivero G; García-Bea A; Gómez-Vallejo V; Callado LF; Llop J; Martín A; Meana JJ
    Transl Psychiatry; 2021 May; 11(1):302. PubMed ID: 34016955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
    Onwordi EC; Halff EF; Whitehurst T; Mansur A; Cotel MC; Wells L; Creeney H; Bonsall D; Rogdaki M; Shatalina E; Reis Marques T; Rabiner EA; Gunn RN; Natesan S; Vernon AC; Howes OD
    Nat Commun; 2020 Jan; 11(1):246. PubMed ID: 31937764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia.
    Brans RG; van Haren NE; van Baal GC; Schnack HG; Kahn RS; Hulshoff Pol HE
    Arch Gen Psychiatry; 2008 Nov; 65(11):1259-68. PubMed ID: 18981337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoid receptor dysregulation underlies 5-HT
    Saunders JM; Muguruza C; Sierra S; Moreno JL; Callado LF; Meana JJ; Beardsley PM; González-Maeso J
    J Biol Chem; 2022 Nov; 298(11):102481. PubMed ID: 36100039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
    Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
    Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia.
    Pralong D; Tomaskovic-Crook E; Opeskin K; Copolov D; Dean B
    Schizophr Res; 2000 Jul; 44(1):35-45. PubMed ID: 10867310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The crosstalk between 5-HT
    Saha S; González-Maeso J
    Neuropharmacology; 2023 Jun; 230():109489. PubMed ID: 36889432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
    Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
    Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM
    Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia.
    Lerond J; Lothe A; Ryvlin P; Bouvard S; d'Amato T; Ciumas C; Daléry J; Poulet E; Saoud M
    J Clin Psychopharmacol; 2013 Feb; 33(1):84-9. PubMed ID: 23277246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
    Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ.
    Schmitt U; Lee DE; Herth MM; Piel M; Buchholz HG; Roesch F; Hiemke C; Lueddens H; Debus F
    Neuropsychobiology; 2011; 63(3):183-90. PubMed ID: 21304228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.